Investing Profile

Joel Dudley

VCInvestor
Venture Partner at Innovation Endeavors
Photo of Joel Dudley, Partner at Innovation Endeavors

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
Stanford University Network
703 CONNECTIONS
Stanford University Network
703 CONNECTIONS
Stanford University Network
703 CONNECTIONS
Asset Management Group Network
216 CONNECTIONS
Asset Management Group Network
216 CONNECTIONS
cb
$100K - $5.0M
$1.5M
7
$1.5B
CompanyStageDateRound SizeTotal Raised
Passkey
SeedOct 2024$20M
$20M
Co-investors: Dana Watt (Breakout Ventures)
Weave
SeedMay 2024$10M
$200M
Co-investors: Matt Garratt (CRV), Joe Montana (Liquid 2 Ventures), Darian Shirazi (Gradient Ventures), Wei Guo (UpHonest Capital), John Mayfield (Album VC), Daniel Curran (FundersClub), Geoff Ralston (Y Combinator), Ronny Conway (A Capital), Ed Roman (Hack VC), Garry Tan (Y Combinator), Edward Lando (Biowear), Christine Aylward (Magnetic Ventures), Jared Friedman (Israel Defense Forces), Eugene Zhang (TSVC Capital), Blake Modersitzki (Pelion Venture Partners), David Silverman (Crosslink Capital), Bryan Rosenblatt (Craft Ventures), Nimay Mehta (Lead Edge Capital), Dmitry Dakhnovsky, Ronny Conway
BioLoomics
SeedSep 2023$9M
$9M
Harmonic Discovery
SeedSep 2022$8M
$8M
Think Bioscience
SeedAug 2022$17M
$72M
Co-investors: Nick Olsen (Innovation Endeavors)
Color
Series UnknownAug 2022
$410M
Co-investors: April Underwood (Obvious Ventures), Hemant Taneja (General Catalyst), Avichal Garg (Electric Capital), Jerry Yang (AME Cloud Ventures), Ling Wong (Highbury Group), Steve Jang (Kindred Ventures), Nikhil Basu Trivedi (Footwork), Max Levchin (Scifi Vc), Ruchi Sanghvi (South Park Commons), Bill Tai (Treasure Data), Chloe Sladden (Broadway Angels), Jerry Yang (Hardware Club), Mariam Naficy (Heretic Ventures), Garry Tan (Y Combinator), Katie Stanton (Moxxie Ventures), Lee Linden (Quiet Capital), Raymond Tonsing (Caffeinated Capital), Ben Davenport (Blockchain Capital LLC), Aaron Levie, Paul Hewson (Bono), Julia Hartz, Drew Houston
Character Biosciences
Series AMay 2022$18M
$130M
Co-investors: Cain McClary (KdT Ventures), Jason P. Hafler (Sanofi Ventures), Milad Alucozai (Entrepreneur First), John Noonan (Lifeforce Capital), Jonathan Roosevelt (Industry Ventures), Vivek Garipalli, Shane Neman
Director of Informatics & Co-founder NuMediiPresent
Associate Professor of Genetics and Genomic Sciences Icahn School of Medicine at Mount SinaiPresent
Endowed Chair of Biomedical Data Science Icahn School of Medicine at Mount SinaiPresent
Director of the Institute for Next Generation Healthcare Icahn School of Medicine at Mount SinaiPresent
Scientific Advisor Thorne HealthTechPresent
Executive Vice President for Precision Health Mount Sinai Health SystemPresent
Scientific Advisor AI TherapeuticsPresent
Associate Editor Molecular Biology and EvolutionPresent
Advisory Board Member Ubalo, Inc.Present
Health 2.0 Engineer and Consultant Connectiv HealthPresent
Partner and Co-founder Foolish Software LLCPresent
Chief Technical Officer Center for Evolutionary Functional Genomics, The Biodesign Institute at Arizona State UniversityPresent
Senior UNIX Programmer DevelopOnline.comPresent
IT Manager Silverware Software Inc.Present
IT Consultant InLynxPresent
IT Helpdesk Technician University of WisconsinPresent
Teaching Fellow Singularity UniversityPresent
Bioinformatics Specialist Stanford UniversityPresent
Consulting Professor of Systems Medicine Stanford University School of MedicinePresent
Chief Scientific Officer Tempus Labs, Inc.Present
Advisory Board Member AyasdiPresent
Scientific Advisor Hoy HealthPresent
Director of Biomedical Informatics Icahn School of Medicine at Mount SinaiPresent
Assistant Professor of Genetics and Genomic Sciences Icahn School of Medicine at Mount SinaiPresent
Senior Vice President, Research Tempus Labs, Inc.Present
Partner Innovation EndeavorsPresent
Investor, Board Member Character BiosciencesPresent
Associate Professor of Genetics and Genomic Sciences (w/ Tenure) Icahn School of Medicine at Mount SinaiPresent
Chief Scientific Advisor Tempus Labs, Inc.Present
Co-Founder and Scientific Advisor Onegevity Health (acquired by THRN)Present
Advisory Board Member Ayasdi IncPresent
Bioinformatics Specialist Stanford University School of MedicinePresent
President and Co-Founder BevimiPresent
Venture Partner Innovation EndeavorsPresent
Investor, Board Member Harmonic DiscoveryPresent
Investor, Board Member Think BiosciencePresent
Scientific Advisor ThornePresent
Chief Scientific Advisor Tempus AIPresent
Chief Scientific Officer Tempus AIPresent
Co-Founder and Scientific Advisor Asset Management GroupPresent
Senior Vice President, Research Tempus AIPresent
Scientific Advisor OrphAI TherapeuticsPresent
Associate Editor Asset Management GroupPresent
Advisory Board Member SymphonyAI Financial ServicesPresent
Consulting Professor of Systems Medicine Stanford Center for Clinical Research (SCCR)Present
Health 2.0 Engineer and Consultant Asset Management GroupPresent
Partner and Co-founder Asset Management GroupPresent
Chief Technical Officer Asset Management GroupPresent
Senior UNIX Programmer Asset Management GroupPresent
IT Manager Asset Management GroupPresent
IT Helpdesk Technician Asset Management GroupPresent
Co-Founder and Scientific Advisor BlueStone Capital Partners, L.P.Present
Director of Informatics & Co-founder Nation of Ellen DeGeneresPresent
Partner and Co-founder BlueStone Capital Partners, L.P.Present
Arizona State University B.S., Microbiology Microbiology
Stanford University PhD, Biomedical Informatics Biomedical Informatics
Stanford University PhD Biomedical Informatics
Arizona State University B.S. Microbiology
Stanford University MS Biomedical Informatics